Bhubaneswar, December 16: Chief Minister Mohan Charan Majhi on Tuesday unveiled the Odisha Pharmaceutical and Medical Devices Policy 2025 with an aim to attract Rs 25,000 crore investment and over 1 lakh employment opportunities in the State by 2030.
The purpose of the policy is to fast-track Odisha as a major hub in the eastern India for pharmaceuticals and medical devices through investment, jobs, innovation and green manufacturing.
The Chief Minister unveiled the policy at the Odisha Pharma Summit-2025 in Bhubaneswar.
The policy aims to attract investment and catalyze local entrepreneurship and MSME growth, while generating employment across skilled and semi-skilled segments and advancing export-oriented manufacturing in APIs, bulk drugs, and medical devices, by developing world-class parks, offering targeted fiscal and non-fiscal incentives, strengthening regulation and skilling, and mobilising Rs 25,000 crore to create over 1 lakh jobs by 2030.
Anchored in the State’s Industrial Policy Resolution (IPR)-2022, which identifies Pharmaceuticals, Bulk Drugs and Medical Devices as a Thrust Sector, the policy promotes infrastructure readiness, research excellence, industry–academia collaboration for skilling and a facilitative regulatory environment to enable inclusive and sustainable industrial development.
Policy Objectives
Anchor assets: Odisha Pharma Park & Odisha MedTech Park (min. 200 acres each) as integrated, Good Manufacturing Practices (GMP)-ready clusters.
Core pillars of the policy:
Infrastructure - IDCO land bank, plug-and-play GMP facilities, common ETP/ZLD, testing & calibration labs, cleanrooms and skill centres inside parks.
Investment promotion & facilitation - Targeted roadshows, annual Odisha Pharmaceutical Leadership Conclave, GO-SWIFT single-window portal integrated with ONDLS/ODLMS for fast clearances.
Institutional structure and delivery - Odisha Pharmaceutical Development Cell (OPDC) as facilitation desk; IPICOL as nodal investment agency; Drugs Controller as technical certifier.
Skilling & talent development - Common Training Centres, industry-academia curricula, NSDC/sector council alignment and incentives for hiring Odisha-domiciled skilled staff.
R&D & innovation - Grants for industry R&D, industry-academia R&D support, and patent subsidies.
Key high-impact incentives:
• Land: 50% subsidy on concessional land cost for units employing ≥200 Odisha-domiciled skilled staff.
• Capital subsidy: 30% on eligible plant & machinery (disbursed up to 6% p.a. for 5 years), without any upper cap.
• Employment Linked Incentive (ELI): ₹12,500/month (male) and ₹15,000/month (female/transgender) for high-skilled staff — for 5 years.
• Incentives for Innovations, Research Development: RCD investment assistance at 50% of the eligible project cost with maximum limit of up to ₹10 crore for MSMEs, ₹25 crore for Large Units, ₹50 crore for Mega Units, ₹100 crore for Anchor Units.
• Power: 25% subsidy (capped ₹1 crore) for dedicated power infrastructure.
• SGST reimbursement: 100% net SGST (capped at 200% of plant & machinery; 300% in Biju Economic Corridor for new units).
• Industrial Park grants: Capital grants up to 50% (max ₹100 crore) for common park infrastructure (first 5 parks).
This policy combines land, finance, skilled workforce, regulatory facilitation and R&D support to attract anchor investments across APIs, formulations, vaccines, diagnostics, imaging, implants and wearables — positioning Odisha as a competitive, sustainable manufacturing & innovation destination.
The policy covers: Pharmaceuticals — Active Pharmaceutical Ingredients (APIs), bulk drugs, formulations, vaccines, biologicals and biosimilars, veterinary drugs and animal vaccines, nutraceuticals, and cosmetics classified as drugs; and Medical Devices — in-vitro diagnostics (IVD), implants, surgical consumables, instruments and apparatus, medical wearables, digital health devices and device software.
For the full policy text, one can refer to Odisha Pharmaceutical & Medical Devices Policy – 2025 available on https://investodisha.gov.in/.
